These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 1571219

  • 1. Response to measles-mumps-rubella vaccine in children on dialysis.
    Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ.
    Pediatr Nephrol; 1992 Mar; 6(2):187-9. PubMed ID: 1571219
    [Abstract] [Full Text] [Related]

  • 2. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 3. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
    Pisón Garcés FJ, Galbe Sánchez-Ventura J, Arcauz Eguren P, Aguirre y Dabán C, Mengual Gil J, Larrad Mur L.
    Aten Primaria; 1995 Mar 15; 15(4):235-7. PubMed ID: 7703334
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response.
    Nakayama T, Urano T, Osano M, Nakagawa M, Maehara N, Sasaki K, Yamamura AM, Makino S.
    Microbiol Immunol; 1990 Mar 15; 34(6):497-508. PubMed ID: 2120551
    [Abstract] [Full Text] [Related]

  • 5. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis.
    Flynn JT, Frisch K, Kershaw DB, Sedman AB, Bunchman TE.
    Adv Perit Dial; 1999 Mar 15; 15():269-72. PubMed ID: 10682116
    [Abstract] [Full Text] [Related]

  • 6. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, Hurni W, Nalin DR.
    Pediatr Infect Dis J; 1996 Aug 15; 15(8):687-92. PubMed ID: 8858673
    [Abstract] [Full Text] [Related]

  • 7. [Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella].
    Just M, Berger R, Glück R, Wegmann A.
    Schweiz Med Wochenschr; 1985 Nov 30; 115(48):1727-30. PubMed ID: 4081704
    [Abstract] [Full Text] [Related]

  • 8. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G.
    Minerva Pediatr; 1989 Mar 30; 41(3):117-22. PubMed ID: 2747598
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 18. Low mumps antibody levels induced by mumps-measles-rubella vaccinations in type 1 diabetic children.
    Hiltunen M, Hyöty H, Leinikki P, Akerblom HK, Tuomilehto J, Vesikari T.
    Diabet Med; 1994 Dec 10; 11(10):942-6. PubMed ID: 7895458
    [Abstract] [Full Text] [Related]

  • 19. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
    Krober MS, Stracener CE, Bass JW.
    JAMA; 1991 Apr 24; 265(16):2095-6. PubMed ID: 2013930
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
    Ljungman P, Fridell E, Lönnqvist B, Bolme P, Böttiger M, Gahrton G, Linde A, Ringdén O, Wahren B.
    J Infect Dis; 1989 Apr 24; 159(4):610-5. PubMed ID: 2647859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.